Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...

NEW YORK (Reuters Health) - The results of new research indicate that many older patients who survive colorectal cancer do not attend the guideline-recommended follow-up office visits or undergo ...

A pair of common tests might help colorectal cancer patients who have undergone surgery remain cancer-free, British researchers say. Both a standard CT scan and a blood test known as CEA ...

Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States. Background: Relapse after ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Palmetto GBA, a Medicare administrative contractor that administers ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The latest market report published by Credence Research, Inc. “Global Carcinoembryonic Antigen (CEA) Market - ...

Blood test for minimal residual disease (MRD) now covered to monitor for disease recurrence after curative intent treatment Tissue-free approach addresses need for cancer patients who have no tissue ...